An MRI before treatment in men undergoing radical prostatectomy can provide independent prognostic value for oncologic ...

Precision Prostate Consulting, LLC announces its rebrand to DeepView Imaging, reflecting the company's mission to provide patients with direct, on-demand access to AI-powered prostate MRI analysis.

A short course of darolutamide (Nubeqa) enhanced the imaging signal of prostate-specific membrane antigen (PSMA)-PET in a ...

Joseph J. Busch, Jr., M.D. , a board-certified radiologist and Founder of the Busch Center in Alpharetta, GA, will give a presentation titled "Robotic Assisted MRI-Guided Transurethral Ultrasound ...

The investment into Lucida Medical is an investment into patented AI software designed to support earlier and more consistent ...

The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...

Lucida’s software is designed to identify prostate cancer ‘within minutes’ and overcome diagnosis delays associated with ...

A Cambridge health tech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately has raised £8.7m in its latest funding round.

Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...

By partnering with other like-minded organizations to fund targeted RFAs throughout the year, ACS is able to invest in new ...

Investigators developed and validated new PSMA-PET-based nomograms for prognostication across prostate cancer stages to help ...

IW Capital has invested in Lucida Medical, a Cambridge and UK healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately.